SEC Form 4 · accession 0001179110-16-031680
ENDOCYTE INC · ECYT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Philip S Low
Officer — Chief Science Officer · Director
Period of report
Nov 15, 2016
Accepted (ET)
Nov 16, 2016 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001235007
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 15, 2016 | M | 15,706 | $2.10 | A | 233,687 | D | |
| Common Stock | holding | — | — | — | 193,318 | I | By spouse trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option(right to buy)F1 | $2.10 | Nov 15, 2016 | M | 15,706 | D | — | Feb 1, 2017 | Common Stock | 15,706 | 0 | D |
Explanation of responses
- F1This option is fully vested and immediately exercisable.